Skip to main content

Table 1

From: Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study

Parameter

Total population

Males

Females

Number

4020

2140

1880

Age (years) a

61.8 (8.1)

61.2 (8.1)

62.2 (8.0)

Diabetes duration (years)

8.4 (6.8)

8.2 (6.9)

8.6 (6.7)

Current smoking (%) c

15.0

18.9

10.5

BMI (kg/m2) a

30.7 (5.2)

30.0 (4.5)

31.6 (5.8)

Blood pressure (mmHg) systolic

139 (17)

139 (17)

140 (18)

- diastolic

82 (9)

82 (9)

82 (9)

Blood glucose (mmol/l) fasting

7.6 (2.5)

7.6 (2.5)

7.5 (2.4)

- postprandialb

9.2 (2.8)

9.3 (2.8)

9.0 (2.7)

HbA1c (%)

7.0 (1.2)

7.0 (1.3)

7.0 (1.2)

Total cholesterol (mmol/l) a

5.5 (1.2)

5.4 (1.2)

5.7 (1.2)

LDL-cholesterol (mmol/l) a

3.2 (1.0)

3.1 (1.0)

3.4 (1.0)

HDL-cholesterol (mmol/l) a

1.3 (0.4)

1.2 (0.3)

1.4 (0.4)

Triglycerides (mmol/l) b

2.2 (1.7)

2.3 (1.8)

2.2 (1.7)

Creatinine (μmol/l) a

82.9 (19.5)

89.2 (18.9)

75.7 (17.6)

Hypertension (%)

91.3

91.3

91.4

Low HDL-cholesterol (%)

9.3

10.0

8.4

Hypertriglyceridaemia (%)

55.4

56.5

54.1

Obesity (%) a

49.8

44.4

55.9

Only diabetes (%)

2.4

2.6

2.2

Antihypertensive therapy (%)

72.9

71.2

74.8

Medical treatment of diabetes (%)

   

- oral drugs

42.3

44.1

40.4

- insulin treatment

44.8

41.0

44.9

Therapy with statins (%) a

27.9

29.3

26.2

Therapy with fibrates (%)

4.2

4.6

3.8

  1. Baseline characteristics of the DIG population divided by sex. Data are mean (SD) and %. Gender differences a p < 0.05; b p < 0.01; c p < 0.001.